TNFRSF10B and neoplasm: We hypothesized that, because of its significantly lower surface DR5 binding on human tumor cells, unlike AMG655 and KMTR2, Lexa would not be an effective Fc-crosslinking partnerfor MD5-1 when murine and human tumor cells were co-cultured (Figure S2E).